In vitro peripheral blood mononuclear cell proliferation, cytokine secretion and oxidative stress modulation by pyrido[2,3-d] pyrimidines

  • Amel Medjdoub
  • Fatima Belhadj
  • Amel Saidi Merzouk
  • Yamina Baba Hamed
  • Zahira Kibou
  • Noureddine Choukchou-Braham
  • Hafida MerzoukEmail author
Original Paper


The aim of this work was to study the in vitro effects of new pyrido[2,3-d] pyrimidines, especially 4-(N-phenylethylamino)-5,7-diphenylpyrido[2,3-d] pyrimidine (3a) and 4-(N-benzylamino)-5-(4-chlorophenyl)-7-(3-methoxyphenyl) pyrido[2,3-d]-pyrimidine (3b), on the proliferative responses of human peripheral blood mononuclear cells, cytokine secretion, ATP levels and intracellular redox status. Peripheral blood mononuclear cells were isolated using differential centrifugation on a density gradient of Histopaque. These cells were cultured with the mitogen concanavalin A (Con A) and with different concentrations of the compounds 3a and 3b (1–100 µM). Proliferation (MTT assay), IL-2, INFγ and IL-4 (Elisa kits), ATP levels, cytotoxic effect (micronucleus test) and oxidative markers (intracellular glutathione, superoxide dismutase, catalase, hydroperoxide and carbonyl protein contents) were investigated after 48-h incubation. Our results showed that 3a was immunostimulant at low concentrations but immunosuppressive at high concentrations (50, 100 µM) with a modulation of cytokine secretion. 3b was immunostimulant in a dose-dependent manner. 3a induced an increase in intracellular ATP levels at 1–25 µM but a decrease at 50–100 µM. In the presence of 3b, cell ATP contents increased with 3b concentrations. Peripheral blood mononuclear cell redox markers were consistent with the presence of an oxidative stress induced by high concentrations of 3a and 3b, with a significant increase in the micronucleus frequency in lymphocytes, suggesting cytotoxic effects. However, 3a at low concentrations (1–25 µM) tended to activate antioxidant defense in cells. In conclusion, 3a and 3b modulate cell-mediated immunity, cell energy and redox status at low concentrations.


Cell ATP Cytokines Peripheral blood mononuclear cells Proliferation Pyrido[2,3-d] pyrimidines Oxidative stress 



This work was financial supported by the ‘Ministère de la Recherche et des Nouvelles Technologies’. The authors thank DGRST and the University of Tlemcen for funding this work.


The authors have no conflicting financial interests.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest regarding the publication of this paper.


  1. Adjei AA, Yamamoto S, Kulkarmi A (1995) Nucleic acids and/or their components: a possible role in immune function. J Nutr Sci Vitaminol 41:1–16CrossRefGoogle Scholar
  2. Attri P, Bhatia R, Gaur J, Arora B, Gupta A, Kumar N, Choi EH (2014) Triethyl ammonium acetate ionic liquid assisted one-pot synthesis of dihydropyrimidinones and evaluation of their antioxidant and antibacterial activities. Arab J Chem 10:1016Google Scholar
  3. Baba Hamed Y, Medjdoub A, Mostefa Kara B, Merzouk H, Villemin D, Narce M (2012) 5,6-Dihydro-2H-pyranones and 5,6-dihydro-2H-pyridones and their derivatives modulate in vitro human T lymphocyte function. Mol Cell Biochem 360:23–33CrossRefGoogle Scholar
  4. Baba Hamed Y, Merzouk H, Harek Y, Medjdoub A, CherrakS Larabi L, Narce M (2014) In vitro effects of nickel (II) and copper (II) complexes with 2,5-bis(2-pyridyl)-1,3,4-thiadiazole on T lymphocyte proliferation and intracellular redox status. Med Chem Res 10:1115–1119Google Scholar
  5. Barile FA (1997) Continuous cell lines as a model for drug toxicity assessment. In: In vitro methods pharmaceutical research, pp 33–54Google Scholar
  6. Belhadj F, Kibou Z, Cheikh N, Choukchou-Braham N, Villemin D (2015) Convenient access to new 4-substituted aminopyrido[2,3-d] pyrimidine derivatives. Tetrahedron Lett 56:5999–6002CrossRefGoogle Scholar
  7. Bennett LR, Blankley CJ, Fleming RW, Smith RD, Tessman DK (1981) Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives. J Med Chem 24(4):382–389CrossRefGoogle Scholar
  8. Bouamama S, Merzouk H, Medjdoub A, Merzouk-Saidi A, Merzouk SA (2017) Effects of exogenous vitamins A, C, and E and NADH supplementation on proliferation, cytokines release, and cell redox status of lymphocytes from healthy aged subjects. Appl Physiol Nutr Metab 42:579–587CrossRefGoogle Scholar
  9. Cope AP (2002) Studies of T-cell activation in chronic inflammation. Arthritis Res 4:197–211CrossRefGoogle Scholar
  10. Dave CG, Shukla MC (1997) Diethyl ethoxymethylene malonate in triheterocycles: a new synthesis of pyrido[3,2-e]pyrimido[1,2-c]pyrimidines. Heterocycl Chem 34:1805–1808CrossRefGoogle Scholar
  11. Djelti F, Merzouk H, Merzouk SA, Narce M (2015) In vitro effects of oil’s fatty acids on T cell function in gestational diabetic pregnant women and their newborns. J Diabetes 7:512–522CrossRefGoogle Scholar
  12. Dwyer JM, Johnson C (1981) The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol 46:237–249Google Scholar
  13. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E (2003) Humn project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534(1–2):65–75CrossRefGoogle Scholar
  14. Gangjee A, Adair O, Queener FS (2001) Synthesis of 2, 4-diamino-6-(thioarylmethyl) pyrido [2,3d] pyrimidines as dihydrofolate reductase inhibitors. Bioorg Med Chem 9:2929–2935CrossRefGoogle Scholar
  15. Ghilsoo N, Cheol MY, Euikyung K, Chung KR, Joong HK, Jung HS, Sung HK (2001) Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors. Bioorg MedChem Lett 11:611CrossRefGoogle Scholar
  16. Grivsky EM, Lee S, Sigel CW, Duch DS, Nichol CA (1950) Synthesis and antitumor activity of 2,4 diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d] pyrimidine. J Med Chem 23:327–329CrossRefGoogle Scholar
  17. Hadzic T, Li L, Cheng N, Walsh SA, Spitz DR, Knudson CM (2005) The role of low molecular weight thiols in T lymphocyte proliferation and IL-2 secretion. J Immunol 175:7965–7972CrossRefGoogle Scholar
  18. Hildeman DA, Mitchell T, Teague TK (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10(6):735–744CrossRefGoogle Scholar
  19. Hou J, Wan S, Wang G, Zhang T, Li Z, Tian Y, Yu Y, Wu X, Zhang JD (2016) Synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. Eur J Med Chemistry 118:276–289CrossRefGoogle Scholar
  20. Kotaiah Y, Nagaraju K, Harikrishna N, Rao CV, Yamini L, Vijjulatha M (2014) Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4 b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines. Eur J Med Chem 75:195–202CrossRefGoogle Scholar
  21. Lagoga IM (2005) Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2:1–49CrossRefGoogle Scholar
  22. Lang-Rollin ICJ, Rideout HJ, Noticewala M, Stefanis L (2003) Mechanisms of caspase-independent neuronal death: energy depletion and free radical generation. J Neurosci 23:11015–11025CrossRefGoogle Scholar
  23. Medjdoub A, Merzouk SA, Merzouk H, Chiali FZ, Narce M (2011) Effects of mancozeb and metribuzin on in vitro proliferative responses and oxidative stress of human and rat spleen lymphocytes stimulated by mitogens. Pestic Biochem Physiol 101(1):27–33CrossRefGoogle Scholar
  24. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefGoogle Scholar
  25. Murado MA, Vazquez JA (2007) The notion of hormesis and the dose–response theory: a unified approach. J Theor Biol 224:489–499CrossRefGoogle Scholar
  26. Naoyuki K, Hyder J, Raoul H, Kuilenburg A (2013) Purine and pyrimidine metabolism. Emery and Rimoin’s principles and practice of medical genetics. Academic Press, San DiegoGoogle Scholar
  27. Nasr MN, Gineinah MM (2002) Pyrido[2,3-d]pyrimidines and pyrimido[5′,4′:5, 6]pyrido[2,3-d] pyrimidines as new antiviral agents: synthesis and biological activity. Arch Pharm Pharm Med Chem 335(6):289–295CrossRefGoogle Scholar
  28. Phillips BJ, James TEB, Andersen D (1984) Genetic damage in CHO cells exposed to enzymatically generated active oxygen species. Mutat Res 126:265–271CrossRefGoogle Scholar
  29. Reck F, Alm R, Brassil P, Newman J, DeJonge B, Eyermann CJ, Breault G, Breen J, Comita- Prevoir J, Cronin M, Davis H, Ehmann D, Galullo V, Geng B, Grebe T, Morningstar M, Walker P, Hayter B, Fisher S (2011) Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity. J Med Chem 54(22):7834–7847CrossRefGoogle Scholar
  30. Resch K, Bessler W (1981) Activation of lymphocyte populations with concanavalin A or with lipoprotein and lipopeptide from the outer cell wall of Escherichia coli: correlation of early membrane changes with induction of macromolecular synthesis. Eur J Biochem 115:247–252CrossRefGoogle Scholar
  31. Schmidtke JR, Hatfield S (1976) Activation of purified human T cells by mitogens: diminished mitogen-induced deoxyribonucleic acid synthesis in human T cells compared with autologous peripheral blood lymphocytes. Infect Immun 13:1061–1068Google Scholar
  32. Shamroukh AH, Rashad AE, Abdelmegeid FME (2016) The chemistry of pyrido[2,3-d]pyrimidines and their applications. J Chem Pharm Res 8(3):734–772Google Scholar
  33. Shan X, Aw TY, Jones DP (1994) Glutathione-dependent protection against oxidative injury. Pharmacol Ther 47:61–71CrossRefGoogle Scholar
  34. Shaoyong KE, Liqiao SHI, Zhigang Z, Ziwen Y (2011) Steroidal[17,16-d]pyrimidines derived from dehydroepiandrosterone: a convenient synthesis, antiproliferation activity, structure-activity relationships, and role of heterocyclic moiety. Sci Rep 7:44439Google Scholar
  35. Singh G, Singh G, Yadav AK, Mishraa K (2002) Synthesis and antimicrobial evaluation of some new pyrido[2,3-d]pyrimidines and their ribofuranosides. Indian J Chem 41:430–432Google Scholar
  36. Stella A, Belle KV, Jonghe SD, Louat T, Herman J, Rozenski J (2013) Synthesis of a 2,4,6-trisubstituted 5-cyano-pyrimidine library and evaluation of its immunosuppressive activity in a mixed lymphocyte reaction assay. Bioorg Med Chem Lett 21:1209–1218CrossRefGoogle Scholar
  37. Wahab S, Hussain A (2013) Cytokines as targets for immunomodulation. Int J Pharm Pharm Sci 5:60–64Google Scholar

Copyright information

© Institute of Chemistry, Slovak Academy of Sciences 2019

Authors and Affiliations

  1. 1.Laboratory of Physiology, Physiopathology and Biochemistry of Nutrition, Department of Biology, Faculty of Natural and Life Sciences, Earth and UniverseUniversity of TlemcenTlemcenAlgeria
  2. 2.Laboratoire de Catalyse et Synthèse en Chimie Organique, Faculté des SciencesUniversité de TlemcenTlemcenAlgeria

Personalised recommendations